Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/57191
Full metadata record
DC FieldValueLanguage
dc.creatorSchmid, Heidipt_PT
dc.date.accessioned2012-01-03T10:01:52Z-
dc.date.available2012-01-03T10:01:52Z-
dc.date.created2010pt_PT
dc.date.issued2012-01-03-
dc.date.submitted2011-12-15pt_PT
dc.identifier.other091006008pt_PT
dc.identifier.urihttp://hdl.handle.net/10216/57191-
dc.descriptionMestrado em Oncologiapt_PT
dc.descriptionMaster Degree in Oncologypt_PT
dc.format.mimetypeapplication/pdfpt_PT
dc.languageporpt_PT
dc.publisherInstituto de Ciências Biomédicas Abel Salazarpt_PT
dc.publisherICBASpt_PT
dc.rightsopenAccesspt_PT
dc.subjectPortopt_PT
dc.title" Aromatase and the Pharmacogenomic Profile - Influence of CYP19A1 polymorphisms in the response of breast cancer patients treated with aromatase inhibitors".pt_PT
dc.typeDissertaçãopt_PT
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar-
dc.identifier.doi10.34626/4n3s-6s55-
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar-
thesis.degree.grantorUniversidade do Porto-
thesis.degree.level1-
dc.identifier.isnihttps://isni.org/isni/0000000406209614-
dc.identifier.rorhttps://ror.org/043pwc612-
Appears in Collections:ICBAS - Dissertação

Files in This Item:
File Description SizeFormat 
Tese de Mestrado Oncologia 2011.pdf7.56 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.